{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:02:16Z","timestamp":1789653736019,"version":"4.0.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.nucmedbio.2022.108313","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T12:05:01Z","timestamp":1672401901000},"page":"108313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA)"],"prefix":"10.1016","volume":"116-117","author":[{"given":"Ting-Yu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Che","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sie-Ong","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2022.108313_bb0005","first-page":"1858","article-title":"Evaluation of pharmacokinetics of 4-borono-2-[18F]-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption","volume":"46","author":"Hsieh","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0010","first-page":"302","article-title":"Evaluation of 4-borono-2-[18F]-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model","volume":"45","author":"Wang","year":"2004","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.nucmedbio.2022.108313_bb0015","first-page":"334","article-title":"Salvage boron neutron capture therapy for malignant brain tumor patients in compliance with emergency and compassionate use: evaluation of 34 cases in Taiwan","volume":"10","author":"Chen","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0883-2889(91)90133-L","article-title":"Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D, L-phenylalanine: a target compound for PET and boron neutron capture therapy","volume":"42","author":"Ishiwata","year":"1991","journal-title":"Int J Rad Appl Instrum A"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0969-8051(97)00078-4","article-title":"Fluorine-18-labeled fluorine gas for synthesis of tracer molecules","volume":"24","author":"Bergman","year":"1997","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12149-018-1268-6","article-title":"Reliable radiosynthesis of 4-[10B]boron-2-[18F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis","volume":"32","author":"Ishiwata","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0035","first-page":"60 1606","article-title":"Synthesis of 4-borono-2-[18F]-fluoro-phenylalanine using copper-mediated nucleophilic radiofluorination","author":"Yoshimoto","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0040","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1039\/D1CC03369G","article-title":"Nucleophilic radiosynthesis of boron neutron capture therapy-oriented PET probe [18F]FBPA using aryldiboron precursors","volume":"57","author":"He","year":"2021","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.564809","article-title":"Review of the correlation of LAT1 with diseases: mechanism and treatment","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Chem"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0050","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2967\/jnumed.112.112284","article-title":"Production at the curie level of no-carrier-added 6-[18F]-fluoro-L-dopa","volume":"54","author":"Libert","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12149-019-01347-8","article-title":"4-Borono-2-[18F]-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research","volume":"33","author":"Ishiwata","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jlcr.600","article-title":"Synthesis of 4-dihydroxyboryl-2-[18F]fluorophenylalanine with relatively high-specific activity","volume":"45","author":"V\u00e4h\u00e4talo","year":"2002","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00259-006-0154-y","article-title":"Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET","volume":"34","author":"Havu-Aur\u00e9n","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107964","article-title":"Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics","volume":"230","author":"Kanai","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.nucmedbio.2022.108313_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000466688","article-title":"Serum amino acid profiles in Normal subjects and in patients with or at risk of alzheimer dementia","volume":"7","author":"Corso","year":"2017","journal-title":"Dement Geriatr Cogn Dis Extra"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805122023071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805122023071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:31:09Z","timestamp":1760848269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805122023071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":15,"alternative-id":["S0969805122023071"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.108313","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA)","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.108313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108313"}}